KCNMA1-linked channelopathy

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetics of cardiomyopathy and channelopathy

During the past 20 years, we have witnessed a dramatic increase in our knowledge of the genetic basis of the cardiomyopathies and the primary electrical disorders (‘‘ion channelopathies’’). This review aims to provide an overview of the different genes linked to these disorders to date. Heart Metab. 2008;41:5–10.

متن کامل

Role of KCNMA1 in Breast Cancer

KCNMA1 encodes the α-subunit of the large conductance, voltage and Ca(2+)-activated (BK) potassium channel and has been reported as a target gene of genomic amplification at 10q22 in prostate cancer. To investigate the prevalence of the amplification in other human cancers, the copy number of KCNMA1 was analyzed by fluorescence-in-situ-hybridization (FISH) in 2,445 tumors across 118 different t...

متن کامل

Pain as a channelopathy.

Mendelian heritable pain disorders have provided insights into human pain mechanisms and suggested new analgesic drug targets. Interestingly, many of the heritable monogenic pain disorders have been mapped to mutations in genes encoding ion channels. Studies in transgenic mice have also implicated many ion channels in damage sensing and pain modulation. It seems likely that aberrant peripheral ...

متن کامل

Dendritic h Channelopathy in Epileptogenesis

Recent work has suggested a link between h channels and epilepsy. In this issue of Neuron, Shah et al. demonstrate that a robust, postseizure decrease in h channels during a critical phase of epileptogenesis mechanistically underlies dendritic hyperexcitability in entorhinal-hippocampal pyramidal cells.

متن کامل

Amplification of KCNMA1: A Potential Therapeutic Target in Prostate Cancer

Prostate cancer is the most common cancer in males and the second leading cause of cancer deaths in western countries. Although most prostate cancers initially respond well to androgen withdrawal, they become inevitably resistant to this treatment and progress to hormone-insensitive disease after only a few months or years. The therapeutic options in these advanced tumors are very limited. The ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of General Physiology

سال: 2019

ISSN: 0022-1295,1540-7748

DOI: 10.1085/jgp.201912457